Patients are eligible for enrolment in the study if they are : diagnosed with moderate to severe AD within the atopic syndrome , aged between 8 and 18years , fluent in the Dutch language , have internet access at home , able to use the digital patient system Digital Eczema Center Utrecht ( DECU ) , willing and able to stay in Davos for a six week treatment period .